骨重建失衡导致骨质疏松发生的作用机制及其药(8)

[34] 牛晓辉,刘巍峰.地舒单抗临床应用安全性的思考[J].中国骨与关节杂志,2018,7(9):641-645.

[35] REID IR,MASON B,HORNE A,et controlled trial of calcium in healthy older women.Am J Med.2006;119(9): 777-785.

[36] YAVROPOULOU MP,MAKRAS P,ANASTASILAKIS for the treatment of Opin ;20(10):1201-1210.

[37] KINOSHITA M,ISHIJIMA M,KANEKO H,et al.The increase in bone mineral density by bisphosphonate with active vitamin D analog is associated with the serum calcium level within the reference interval in postmenopausal ;29(1):157-164.

[38] AYDOGAN NH,OZEL I,ILTAR S,et al.The effect of vitamin D and bisphosphonate on fracture healing: An experimental study.J Clin Orthop ;7(2):90-94.

[39] RAZAQ A,KHAN S,HASSAN J,et the efficacy and safety of denosumab with bisphosphonates in increasing bone mineral density in patients with prostate cancer and breast cancer on antihormonal ;11(12):e6401.

[40] MOHSIN S,O'BRIEN FJ,LEE crack barriers in ovine compact bone.J ;208(1):81-89.

[41] TAO ZS,ZHOU WS,WU XJ,et of ovariectomy- induced osteoporosis in rats : Comparative study of zoledronic acid,parathyroid hormone (1-34) and strontium Gerontol ;52(2):139-147.

[42] REGINSTER JY,HATTERSLEY G,WILLIAMS GC,et is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Tissue Int.2018;103(5):540-545.

[43] BESSCHETNOVA T,BROOKS DJ,HU D,et improves cortical geometry and trabecular microarchitecture and increases vertebral and femoral neck strength in a rat model of male ;124:148-157.

[44] LINDSAY R,COSMAN F,ZHOU H,et al.A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of Bone Miner Res.2006;21(3): 366-373.

[45] MA YL,ZENG Q,DONLEY DW,et increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with Bone Miner Res.2006;21(6):855-864.

[46] OHUCHI K,MIYAKOSHI N,KASUKAWA Y,et of teriparatide on bone in autochthonous transgenic model mice for diabetes mellitus (Akita mice).Osteoporos ;5(4): 109-115.

[47] OGAWA T,OHSHIKA S,YANAGISAWA M,et may accelerate the growth of a pre-existing malignant tumor in an elderly patient with osteoporosis: A case Clin ;12(2):144-147.

[48] KITAGUCHI K,KASHII M,EBINA K,et of single or combination therapy of teriparatide and anti-RANKL monoclonal antibody on bone defect regeneration in ;106: 1-10.

[49] 刘颗星,邓颂波,曾日祥,等.特立帕肽在老年性股骨粗隆间骨折保守治疗中对骨密度的影响及其临床疗效[J].临床与病理杂志,2019,39(12):2733-2739.

[50] CHEN Q,GUO M,MA X,et to Teriparatide Treatment and Risk of Fracture: A Systematic Review and Metab Res.2019;51(12):785-791.

[51] RAMCHAND SK,DAVID NL,LEDER BZ,et al.Bone mineral density response with denosumab in combination with standard or high-dose teriparatide: the DATA-HD RCT.J Clin Endocrinol ;105(3).pii: dgz163.

[52] TANAKA S,MORI S,HAGINO H,et of a randomized trial of teriparatide followed by alendronate: Japanese Osteoporosis Intervention Trial-05 (JOINT-05).J Bone Miner ;38(3): 412-417.

[53] 李盛楠,李钒,白玉兴.甲状旁腺激素相关蛋白与骨代谢研究进展[J].基础医学与临床,2017,37(8):1179-1183.

[54] SAHBANI K,CARDOZO CP,BAUMAN WA,et exhibits greater osteoanabolic response and higher cAMP stimulation and beta-arrestin recruitment than Rep.2019;7(19):e.

[55] EASTELL R,MITLAK BH,WANG Y,et al.Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from Int.2019;30(3): 667-673.

[56] LE HENAFF C,RICARTE F,FINNIE B,et at the Same Dose Has the Same Effects on Bone as PTH (1-34) in Mice.J Bone Miner

[57] ARDURA JA,PORTAL-NUNEZ S,ALONSO V,et parathormone receptor type 1 in skeletal diseases: realities and expectations of Endocrinol ;30(10):756-766.

[58] MILLER PD,HATTERSLEY G,RIIS BJ,et of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical ;316(7):722-733.

[59] DOYLE N,VARELA A,HAILE S,et ,a novel PTH receptor agonist,increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone Int.2018;29(3):685-697.

[60] SATO M,WESTMORE M,MA YL,et [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing Bone Miner Res.2004;19(4):623-629.

[61] DEMPSTER DW,COSMAN F,KURLAND ES,et of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.J Bone Miner Res.2001;16(10):1846-1853.

[62] WASHIMI Y,ITO M,MORISHIMA Y,et of combined humanPTH(1-34) and calcitonin treatment in ovariectomized ;41(5):786-793.

[63] BARON R,RAWADI G.Wnt signaling and the regulation of bone Osteoporos Rep.2007;5(2):73-80.

文章来源：《力学季刊》 网址: http://www.lxjkzz.cn/qikandaodu/2021/0208/335.html